Загрузка страницы

Using Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines .. | Ann Chahroudi, MD, PhD

Lecture: Using Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines and Cure
Speaker: Ann Chahroudi, MD, PhD
Emory University, United States of America
Presented at: International Workshop on HIV & Pediatrics 2017

Learn more about the International Workshop on HIV Pediatrics 2021 that will take place from 16 July 2021 to 17 July 2021 via https://bit.ly/3hH2SRQ

The treatment of pediatric HIV infection, particularly of infants and young children, remains complex and problematic. Rapid growth and organ system maturation, as well as emotional and cognitive changes that occur across the developmental spectrum from infancy through adolescence, complicate drug development, and administration. Adherence outcomes in children have been less than robust and mental health and behavioral issues are emerging as critical to understand and address in order to ensure the success of long-term treatment. Additionally, while fewer infected children are being born, there are increasing concerns about the long-term impact of in utero and post-natal exposures to antiretroviral drugs for those children who escape HIV. Currently, an estimated 20% of all infants born in sub-Saharan Africa are exposed to HIV and antiretrovirals during pregnancy and the post-natal period.

The pediatric HIV cure agenda is an important emerging area of research. Early infant diagnosis is increasingly available globally, enabling the earlier identification of infection and provides new exciting opportunities to study acute infection in children and promising cure strategies. The HIV Pediatrics Workshop is the only meeting entirely devoted to research in the prevention and treatment of HIV infections in infants, children, and adolescents, making it the premier forum for the world’s leading researchers.

Registration for the webinar is open and fee is waived for healthcare professionals via this link https://bit.ly/3hDpMtf

For the Enduring Materials of the 2017 edition visit https://bit.ly/3bD6MaF

For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/

Видео Using Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines .. | Ann Chahroudi, MD, PhD канала Academic Medical Education
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
18 марта 2021 г. 16:27:36
00:22:24
Другие видео канала
Preview: Highlights International Workshop on HIV & Women 2021 | Sharon Walmsley, FRCPC, MD, MSCPreview: Highlights International Workshop on HIV & Women 2021 | Sharon Walmsley, FRCPC, MD, MSCA new model for early clinical development of TB drugs and its application... | Norbert Heinrich, MDA new model for early clinical development of TB drugs and its application... | Norbert Heinrich, MDClinical Considerations of Aging People Living with HIV - Marta BoffitoClinical Considerations of Aging People Living with HIV - Marta BoffitoThe ABC of viral hepatitis | Mark Thursz, MRCPThe ABC of viral hepatitis | Mark Thursz, MRCPUpdates on WHO HIV Treatment Guidelines - Fujie Zhang, MD, PhDUpdates on WHO HIV Treatment Guidelines - Fujie Zhang, MD, PhDIs HCV drug resistance an issue? | Jürgen Rockstroh, MDIs HCV drug resistance an issue? | Jürgen Rockstroh, MDIs NAFLD/NASH a Public Health Challenge in 2022? - Zobair M. Younossi, MD, MPH, FACG, FACP, AGAFIs NAFLD/NASH a Public Health Challenge in 2022? - Zobair M. Younossi, MD, MPH, FACG, FACP, AGAFAntiretroviral Therapy in Pregnant Women with HIV and Neonates - Lijun SunAntiretroviral Therapy in Pregnant Women with HIV and Neonates - Lijun SunLong Acting Antivirals for Treatment and Prevention | Martin Markowitz, MDLong Acting Antivirals for Treatment and Prevention | Martin Markowitz, MDExercise and aging | Wendy Kohrt, PhDExercise and aging | Wendy Kohrt, PhDSymposium 1: ViiV - What’s New in HIV Treatment & Prevention for Youth? - Panel DiscussionSymposium 1: ViiV - What’s New in HIV Treatment & Prevention for Youth? - Panel DiscussionInvitation to join the HIV Prevention Review Meeting 2022 - 30-31 MarchInvitation to join the HIV Prevention Review Meeting 2022 - 30-31 MarchCase-Based Discussion of Oral Antivirals for COVID-19: Part 1  - Catia Marzolini, PharmD, PhDCase-Based Discussion of Oral Antivirals for COVID-19: Part 1 - Catia Marzolini, PharmD, PhDAnti-HBV potential of PD-1/PD-L1 blockade in chronic HBV infection | Daniel VerdonAnti-HBV potential of PD-1/PD-L1 blockade in chronic HBV infection | Daniel VerdonResearch into Aging with HIV: Lessons Learned and Outstanding Challenges - Peter ReissResearch into Aging with HIV: Lessons Learned and Outstanding Challenges - Peter ReissState of the Art Interventions in Improving Pediatric HIV Outcomes in OVC Programs - Grace MayanjaState of the Art Interventions in Improving Pediatric HIV Outcomes in OVC Programs - Grace MayanjaInvitation by Roger Paredes, MD, PhD | European Meeting on HIV & Hepatitis 2021Invitation by Roger Paredes, MD, PhD | European Meeting on HIV & Hepatitis 2021Differentiated & Simplified PrEP for HIV Prevention | Heather-Marie Schmidt, BMedSc (Hon), MPH, PhDDifferentiated & Simplified PrEP for HIV Prevention | Heather-Marie Schmidt, BMedSc (Hon), MPH, PhDAcute hepatitis A to E, diagnosis and management | Thomas Berg, MDAcute hepatitis A to E, diagnosis and management | Thomas Berg, MDDoes resistance still matter? | Daniel Kuritzkes, MDDoes resistance still matter? | Daniel Kuritzkes, MD
Яндекс.Метрика